(Q30979259)

27 June 2017

title

Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2. (English)

1 reference

27 June 2017

Hideomi Yamagami

1

1 reference

27 June 2017

Tatsuo Nishioka

2

1 reference

27 June 2017

Eiji Ochiai

3

1 reference

27 June 2017

Kazuyo Fukushima

4

1 reference

27 June 2017

Masaaki Nomura

5

1 reference

27 June 2017

Shohei Kasugai

6

1 reference

27 June 2017

Shuzo Moritani

7

1 reference

27 June 2017

Koichi Yokogawa

8

1 reference

27 June 2017

Ken-ichi Miyamoto

9

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

27 June 2017

published in

Biochemical Pharmacology

1 reference

27 June 2017

volume

66

1 reference

27 June 2017

issue

5

1 reference

27 June 2017

page(s)

801-807

1 reference

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Inhibition of a high affinity cyclic AMP phosphodiesterase and relaxation of canine tracheal smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Selective tracheal relaxation and phosphodiesterase-IV inhibition by xanthine derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Trypsinized osteoclast-like multinucleated cells formed in rat bone marrow cultures efficiently form resorption lacunae on dentine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Separation of mouse spleen cells by passage through columns of sephadex G-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Osteoporosis-like changes in Walker carcinoma 256-bearing rats, not accompanied with hypercalcemia or parathyroid hormone-related protein production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

A novel molecular mechanism modulating osteoclast differentiation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Prostaglandin E2 inhibits formation of osteoclastlike cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Cell biology of the osteoclast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3?,5?-monophosphate phosphodiesterase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Mechanism for the emetic side effect of xanthine bronchodilators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900409-X

10.1016/S0006-2952(03)00409-X

7 January 2021

Identifiers

DOI

1 reference

27 June 2017

1 reference